图片: | |
---|---|
名称: | |
描述: | |
性别 | 女 | 年龄 | 74 | 临床诊断 | 女 74岁 绝经20年后阴道流血 |
---|---|---|---|---|---|
一般病史 | 女 74岁 绝经20年后阴道流血 | ||||
标本名称 | 女 74岁 绝经20年后阴道流血 | ||||
大体所见 | 女 74岁 绝经20年后阴道流血 左侧卵巢2.5cm*0.8cm*0.7cm |
女 74岁 绝经20年后阴道流血
左侧卵巢2.5cm*0.8cm*0.7cm
Sertoli-Leydig细胞肿瘤
Sertoli-Leydig细胞肿瘤? Sertoli cell tumor?
Do IHC
Sertoli-Leydig细胞肿瘤
positive:
Testosterone, estradiol, cytokeratin, AFP CD99 ¨, inhibin alpha, low molecular weight cytokeratin, anti-Mullerian hormone focally progesterone receptor, androgen receptor and vimentin,
Negative:
EMA, PLAP, CEA, CA19-9, CA125 and S100 (use to distinguish from carcinosarcoma)
Sertoli cell tumor
positive
Inhibin, vimentin, CD99, CD10, AE1-3 or CAM5.2 (usually), calretinin (50%), variable smooth muscle actin and S100
negative
EMA, chromogranin
min wang
Sertoli-Leydig细胞肿瘤? Sertoli cell tumor?
Do IHC
Sertoli-Leydig细胞肿瘤
positive:
Testosterone, estradiol, cytokeratin, AFP CD99 ¨, inhibin alpha, low molecular weight cytokeratin, anti-Mullerian hormone focally progesterone receptor, androgen receptor and vimentin,
Negative:
EMA, PLAP, CEA, CA19-9, CA125 and S100 (use to distinguish from carcinosarcoma)
Sertoli cell tumor
positive
Inhibin, vimentin, CD99, CD10, AE1-3 or CAM5.2 (usually), calretinin (50%), variable smooth muscle actin and S100
negative
EMA, chromogranin